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Abstract Oxygen is the basic molecule which supports life
and it truly is “god's gift to life.” Despite its immense impor-
tance, research on “oxygen biology” has never received the
light of the day and has been limited to physiological and
biochemical studies. It seems that in modern day biology,
oxygen research is summarized in one word “hypoxia.” Sci-
entists have focused on hypoxia-induced transcriptomics and
molecular–cellular alterations exclusively in disease models.
Interestingly, the potential of oxygen to control the basic
principles of biology like homeostatic maintenance, transcrip-
tion, replication, and protein folding among many others, at
the molecular level, has been completely ignored. Here, we
present a perspective on the crucial role played by oxygen in
regulation of basic biological phenomena. Our conclusion
highlights the importance of establishing novel research areas
like oxygen biology, as there is great potential in this field for
basic science discoveries and clinical benefits to the society.
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1 Introduction
The emergence of an oxygen-based atmosphere altered the
basic cellular molecular organization of primitive cells to their
multicellular forms. With the emergence of multicellular life,
our understanding of the role of oxygen became limited to its
association with energy generating pathways. Modern science
is not focusing on the involvement of oxygen in basic biolog-
ical processes like DNA replication, transcription, translation,
protein modifications, cellular signaling, and cell death.
In our opinion, oxygen-dependent regulation of the molec-
ular machinery of cells is a central process in disease devel-
opment and understanding these processes will result in novel
therapeutic strategies. Diseased organs show altered oxygen
signaling in comparison to healthy ones. Diseases of global
concern including cancer, cardiac disease, and neurological
disease have an underlying component of oxygen-based mod-
ifications of cellular and molecular machineries. However,
there is a basic biology side to this research which again is
ignored, and scientific efforts here have the potential to pro-
vide society with major scientific breakthroughs.
Interestingly, health benefits of ancient eastern practices
of oxygen-based exercises, including pranayam, which is a
practice of artificially controlling breathing rates have reg-
ularly been reported [1]. Again, in our opinion if oxygen
has the potential to show health benefits, then the accom-
panying changes in cellular and molecular biology should
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be understood. The basic biological information of the
impact oxygen has on cellular processes will help strategize
present day therapies.
Several reports have focused on the role of oxygen availability
in disease models such as hypoxic tumors [2], myocardial in-
farction [3], hyperoxic lung injury [4], and hyperoxic retinopathy
[5], but the focus has remained on hypoxia and disease physiol-
ogy. One single area which deals with hypoxia, cancer, and
cardiovascular diseases in relation with HIF transcription factor
has been researched in-depth manner at the molecular level.
Despite the fact that oxygen plays a critical role in the
regulation of the molecular processes of life, there is no report
which comprehensively presents and summarizes this point of
view. The present review integrates existing research at the
molecular level along with our understanding of the impact of
oxygen on the basic biological processes of life such as
transcription, DNA replication, cell cycle progression, protein
folding, apoptosis, senescence, and cellular motility. This
review highlights the importance of oxygen biology as a
research area and the need for the recognition of this interest-
ing yet untouched research field.
2 Role of oxygen in regulation of cellular transcription
The impact of oxygen on transcription holds significant im-
portance as it facilitates a rapid, reversible, and well-controlled
response to oxygen fluctuations. The survival of cells, wheth-
er physiological or pathological, depends on energy produc-
tion through oxygen. Low oxygen availability is a cellular
stress, and as a response to this, the cellular system evokes
changes in transcriptional and signaling pathways to over-
come stress-induced cell death. Although these systems are
designed for the survival of non-pathological cells, several
types of cancers that form solid tumors andmetastasize exploit
oxygen-dependent transcriptional machinery. Hypoxia-
inducible factors (HIFs) play a central role in mediating these
pro-survival changes by transcriptionally activating genes
involved in the regulation of cellular metabolism, angiogene-
sis, cell proliferation, and viability [6] (Fig. 1). After activa-
tion, HIF1α moves to the nucleus and binds to the consensus
DNA site BACGTSSK (B = G/C/T, K = G/T, and S = G/C),
termed as the hypoxia response element (HRE) [7]. Several
established targets of HIF1a (like VEGF, NOS2, EPO [8, 9])
help in maintaining the metabolic and divisional balance of
the hypoxic cells. Emerging targets of HIF1α show its in-
volvement in regulating cellular differentiation (ID2 and
Gelactin-1), cell survival (cyclooxygenase-2), proliferation
(c-myc), metastasis (snail), etc. [10–15]. Thus, HIFs-
dependent regulation of transcription of these genes results
in maintenance of cellular homeostasis, saving hypoxic cells
from death or senescence. Maintaining cellular metabolism is
a critical homeostatic response during oxygen shortage since
the lack of oxygen limits oxidative phosphorylation
(OXPHOS), pushing cells towards higher glycolysis. HIF1α
increases glucose influx by inducing glucose transporters
GLUT1 and GLUT3 [16, 17], and upregulates the expression
of MCT-4 to help increase the efflux of lactic acid in hypoxic
cells exhibiting higher glycolytic rates [18] (Fig. 1). Several
enzymes of the glycolytic pathway like aldolase A, phospho
glycerate kinase 1, and pyruvate kinase are directly induced
byHIF1α [19]. HIF1α upregulates the expression of PFKFB3
gene and fructose-2,6-bisphosphate which allosterically acti-
vates 6-phosphofructo-1-kinase (PFK-1), thereby increasing
rates of cellular glycolysis in hypoxic cells [20] (Fig. 1). Thus,
pathways that ensure energy generation through glycolysis in
hypoxic cell are transcriptionally induced by HIF1α. The
reduction in OXPHOS is an expected outcome which is also
achieved by alterations in the transcriptional machinery.
HIF1α activates pyruvate dehydrogenase kinase-1 which
phosphorylates pyruvate dehydrogenase resulting in lower
acetyl-CoA and thus reduced input into the tricarboxylic acid
cycle [21, 22]. Another mechanism to optimize oxygen usage
includes a subunit switch in cytochrome c oxidase (COX)
during hypoxia, which is driven by HIF1α-dependent tran-
scription of COX4 and Lon which favors COX4-2 subunits
over COX4-1 [23]. Thus, in rapidly dividing cancer cells
which often experience low oxygen levels, there exists an
intricate network of HIF1α-mediated transcriptional regula-
tion which functions as elegant oxygen shortage-sensing ma-
chinery and alters cellular transcription to maintain homeosta-
sis and fulfill critical energy demands of hypoxic cancer cells.
Oxygen alterations, especially hyperoxia-induce redox im-
balance in cells and its maintenance is a crucial step in achiev-
ing cellular homeostasis. The NF-κB family of proteins are
emerging as important transcription factors (TF) responsible
for maintaining redox homeostasis. Disturbance of redox bal-
ance under hyperoxia [24] results in redox-dependent activa-
tion of NF-κB [25, 26], in addition to other transcriptional
factors like AP-1, specificity protein-1 (SP-1), and p53
[27–29]. The NF-κB–thioredoxin system maintains oxygen-
dependent homeostasis by regulating cellular expression of
the proteins thioredoxin (Trx), thioredoxin reductase, and
NADPH [30]. Trx reduces the oxidized cysteins of several
transcription factors, thereby exercising a redox control on
their function [31]. Furthermore, Trx functions as a peroxide
scavenger through the peroxiredoxin (Prx) proteins which
reduce peroxides like H2O2 [32]. Trx stabilizes NF-κB and
increases transcription at HIF1α promoter to upregulate its
expression [33, 34]. By reducing cysteine in HIF1α, Trx
facilitates the co-activation of HIF1α by CBP/p300 and in-
creases its transcriptional activity [33] (Fig. 2). Since ROS-
quenching prevents dissociation of inhibitor of NF-κB (IκB)
and NF-κB [35], Trx (by scavenging ROS) may also prevent
the ROS-mediated degradation of IκB, in essence preventing
NF-κB activation. In contrast, NF-κB-mediated nuclear
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translocation of Trx causes reduction of a cysteine in NF-κB,
thereby increasing the transcriptional activity of NF-κB [34]
(Fig. 2). The contrasting role of oxygen-dependent NF-κB
activation through Trx in the cytoplasm and nucleus may
indicate a stringent control over transcriptional activity of
NF-κB. Since levels of Trx are upregulated in many cancers
and correlate with increased growth, invasiveness, metastasis,
and therapy resistance, it implicates oxygen's role in influenc-
ing carcinogenesis by modifying cellular redox environment.
In addition to NF-κB-mediated signaling, several oth-
er transcription factors are also known to respond to
ROS availability, mostly facilitating an invasive and
motile phenotype. ROS mediated activation of AP-1
and Smad, and transcriptional upregulation of Est-1 is
known [36]. The activation of these transcription factors
is pivotal in cancer metastasis and exemplifies how
oxygen-dependent transcriptional changes influence the
behavior of cancer cells by coordinated changes to gene
expression.
While transcription factors enable transient control, a stable
change in oxygen availability requires a more permanent
response from stressed cells in order to support their survival.
Knowledge on long-term changes to transcription is essential,
since the multistep process of cancer and metastasis may be
speculated to utilize long-term transcriptional changes that can
be traced back to their oxygen “niches.” Thus, long-term
transcriptional changes by chromatin remodeling is influenced
by altered reducing or oxidizing atmospheres present in the
tumor tissues, infarct zones of the myocardium, and other
disease models [37]. Oxygen regulates chromatin modifica-
tions through SWI/SNF proteins, histone modifications, in-
corporation of histone variants, and even DNA methylation
Fig. 1 Role of oxygen in regulating transient and permanent changes to
transcription: transient transcriptional changes to low oxygen are medi-
ated by HIF1α, causing activation of HIF1α-response genes that control
glycolysis, metastasis, apoptosis, cell cycle, and mitochondrial oxygen
consumption. Permanent transcriptional changes under low oxygen occur
through direct modifications on DNA by methylation or through
chromatin remodeling events that cause posttranslational histone modifi-
cations, alter histone subunits in nucleosome, or cause epigenetic remod-
eling through SWI/SNF complexes (here Brg1/Brm). Transcription of
miRNA clusters control gene expression by silencing HIF1α, in effect
changing transcriptional status of HIF1α response genes
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[37], all of which are observed during oncogenesis (Fig. 1).
The SWI/SNF proteins utilize ATP for chromatin remodeling
and altered oxygen levels are known to influence ATP gener-
ation (through OXPHOS). As a result, this might relate SWI/
SNF-mediated chromatin remodeling to oxygen availability
and cellular ATP levels in hypoxic cells. In addition, there
exists direct evidence of SWI/SNF affecting transcriptional
response during oxygen changes. For example, HIF1α was
found associated with SWI/SNF at the enhancer region of its
target gene erythropoietin (EPO) [38, 39]. Upon oxygen dep-
rivation, EPO induction requires HIF1α binding and also the
SWI/SNF association. This provides a link between oxygen
availability (through HIF1α stabilization) and transcriptional
activation by the SWI/SNF chromatin remodeling complex.
Histone proteins associate with DNA and prevent tran-
scriptional activation by hindering the access of transcription-
al machinery to these bound regions, whereas the
posttranslational modifications of histones cause unwinding
of target DNA to enable transcription. Since oxygen-mediated
changes can affect histone modifications, they provide another
tool to exercise long-term transcriptional control. For exam-
ple, acetylation of histones during hypoxia is observed on cell
survival genes such as VEGF andDNA-PKwhich is related to
their activation [40, 41]. Similarly, oxygen governs the meth-
ylation of histones repressing tumor suppressor genes like
BRCA1, RUNX3 [42, 43], probably based on the level of
oxygen available [37]. Promoter methylation is also regulated
by hypoxia and is found to reduce global methylation [44],
probably to de-repress genes important for tumor progression.
In addition to promoting acetylation and methylation, several
other posttranslational modifications are carried out on his-
tones in direct or indirect response to oxygen availability. As
described previously, CBP/p300 is a HIF1α co-activator and
itself a histone acetyl transferase (HAT). It may be speculated
Fig. 2 Oxygen-induced redox changes regulate cellular transcription:
high oxygen levels, reoxygenation, and acute hypoxia can trigger ROS.
Production of ROS facilitates translocation of NF-κB into the nucleus by
promoting dissociation of IκB from NF-κB, in effect stimulating NF-κB-
mediated transcription. ROS can also activate the Thioredoxins (Trx) that
negatively regulate NF-κB translocation either directly or by quenching
ROS through Prx. In contrast, Trx reduce disulphide linkage in NF-κB
localized in nucleus, causing higher NF-kB-mediated transcriptional
changes. Trx also reduce the disulfide bonds in HIF1α, promoting its
association with the co-activator CPB/p300 and increasing transcriptional
activity
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that under hypoxia, CBP/p300 availability governs both
HIF1α-mediated cellular response (due to CBP/p300 co-
activation) as well as histone modification (through CBP/
p300 HAT activity). Oxygen deprivation leads to activation
of other histone modifiers such as PCAF, Src-3, and even
sirtuins—SIRT1, SIRT3, and SIRT6 [37], in effect, causing
extensive transcriptional changes by utilizing different sensors
of oxygen availability and responders which execute several
combinations of posttranslational modifications. It is notewor-
thy that the extensive repertoire of posttranslational modifica-
tions (solely based on oxygen levels) adds to the advantage
gained by cancer cells in oxygen niches, but at the same time,
oxygen therapies may gain a firm scientific basis towards
fighting cancer.
The transcription of noncoding RNA (ncRNA) expands the
posttranscriptional regulatory potential of oxygen. Noncoding
RNA may either be short (about 22 nucleotides) RNA mole-
cules, as often found in miRNA or long (∼200–100 kb) RNA
molecules called long noncoding RNA (lncRNA). Under
altered oxygen availability, miRNA can govern HIF1α ex-
pression and function. The miRNA cluster miR-17-92,
MicroRNA-519c, and miR-20b cause silencing of HIF1α
[45, 46] and affect the expression of HIF1α target genes
(Fig. 1). One of the critical effects observed by miRNA-
mediated HIF1α silencing is a significant decrease in the
tissue angiogenesis. miR-20b [47] causes reduced VEGF
levels, microRNA-519c reduces angiogenesis [46], and
microRNA-107 (induced by p53) reduces tumor angiogenesis
[48] (Fig. 1). These indicate that reduced oxygen levels affect
transcription not only by stabilization of transcription factors
such as HIF1α but also through the induction of several
miRNAs. Constitutive HIF1α expression during prolonged
hypoxia may be undesirable. Thus, microRNA-155 reduces
the expression by silencing HIF1α during prolonged hypoxia
[49]. The miRNA-mediated response to hypoxia has been
well reviewed [50–52], but few reports exist on lncRNA-
mediated response to hypoxia. In a recent study, it was shown
that hypoxia leads to transcription of intragenic spacer chro-
matin, which act as lncRNAs and associate with proteins
causing their nucleolar localization. This was demonstrated
for the VHL protein where upon hypoxic stress, VHL was
found to be sequestered in the nucleolus thus promoting
HIF1α activity in the cytoplasm [53, 54]. Hypoxia can pro-
mote other posttranscriptional mechanisms such as alternate
splicing of mRNA [55], in addition to ncRNA-mediated con-
trol. Clearly, hypoxia-mediated transcriptional changes play a
pivotal in governing cellular response.
Molecular changes in response to oxygen availability seem
to be critically dependent upon the transcription of target
genes. While an overall reduction in protein synthesis is seen,
specific genes may be expressed during particular oxygen
levels. The role of HIF1α in mediating hypoxia-associated
changes is well established. However, it seems that several
other upstream molecules can control HIF1α-dependent re-
sponse, for example Trx and ncRNA. Additionally, NF-κB-
mediated response to oxygen equips the cell to execute wider
homeostatic functions by utilizing the signaling role of
NF-κB. Some of the notable responses include transcription
genes which promote glycolysis and those which suppress
OXPHOS, adding metabolic control which oxygen can exer-
cise. Thus, transcriptional response represents a crucial cellu-
lar strategy to respond to chronic and acute oxygen changes
by implementing multilayered integration and response mol-
ecules such as proteins and RNA.
3 Oxygen controls cellular DNA replication machinery
DNA replication is a coordinated event that is required to
function in close association with the cell cycle. Eukaryotic
cells respond to growth stimulatory factors by undergoing
mitotic cell division which necessitates DNA duplication.
Cells also ensure that commitment for division occurs under
adequate supply of nutrients; incorrect replication of DNA is
often associated with tumorigenesis. Therefore, DNA replica-
tion (which is a high energy-consuming process) seems to be
well coordinated in response to oxygen availability in cells
which eventually regulates the cellular OXPHOS and ATP
levels. Recent research supports the school of thought where
DNA replication functions downstream of oxygen signaling
and as a result regulates the progression of cells through G1, S,
and G2 check points of the cell cycle.
Oxygen controls the synthesis of deoxyribonucleotides that
are obtained by the reduction of ribonucleotides in a reaction
catalyzed by the enzyme ribonucleotide reductase [56].
Brischwein et al. showed that the enzyme responds to the
partial pressure of oxygen (pO2) and alters the levels of dCTP
in cultured Ehrlich ascite cells. Decreased oxygen levels led to
a reduction in dCTP levels and reduced frequency of the
origin of replication (Fig. 3). Interestingly, this pathway does
not affect the synthesis of other deoxyribonucleotide triphos-
phates. The mechanism of dCTP production seems to be
dependent upon the M2-specific free-radical site in ribonucle-
otide reductase, which is controlled by oxygen. Interestingly,
supplementing dCTP in the media of hypoxia-cultured cells
restored the initiation of replication, suggesting that dCTP acts
as an important mediator in the oxygen signaling and thereby
establishes ribonucleotide reductase a potential oxygen-
sensing enzyme in the hypoxic cells [57]. The members of
the DNA replication machinery such as RPA70 show alter-
ations in their cellular expression levels in response to varying
levels of cellular oxygen [58]. Some proteins in the multi-
protein DNA replication complex are also known to be regu-
lated by oxygen (Fig. 3). For example, Replication Protein A
(a eukaryotic single-strand DNA binding protein) which con-
tains a zinc finger motif in a non-DNA binding domain was
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recently shown to be regulated in hypoxic cancer cells by
Madan et al. [58]. It was reported that the RPA protein re-
sponds to cellular redox environments via alteration of disul-
fide bonding in cysteine residues of the zinc finger motif.
Since oxygen can modulate cellular ROS production, it exe-
cutes redox signaling by altering redox environments. A rel-
ative abundance of oxidants (as found in endoplasmic reticu-
lum) causes oxidation of disulfide bonds of proteins, while the
opposite is observed under reducing environments usually in
the cytoplasm. When the reducing environment for RPA is
mimicked by the reducing agent DTT, about 10-fold higher
ssDNA binding activity is seen. Also, a cysteine–alanine
substitution causes a constitutive ssDNA binding version of
RPA. On the other hand, diamide-mediated oxidation is
shown to reduce DNA binding of RPA [59]. Another redox-
modulated transcription factor is the DNA replication-related
element binding factor (DREF), which was first identified in
Drosophila and later its human homologue was discovered
(ZBED1) [60] (Fig. 3). DREF controls DNA replication by
regulating transcription of genes including PCNA and
Polymerase-α-180 KDa subunit. The DREF consists of three
critical redox-regulated cysteine residues in its DNA binding
domain. Two out of these three cysteine residues, Cys59 and
Cyst62, are readily reduced and the reduced form prevents the
DREF-DNA interaction, resulting in reduced transcriptional
activation of the replication-associated genes [61]. This path-
way might hold significant importance in cancer cells, since
tumors exhibit redox-sensitive environments. Reactive oxy-
gen species produced during hyperoxia [62] such as singlet
oxygen is reported to directly damage PCNA and thus nega-
tively affecting DNA replication [63]. The immediate effect of
altering oxygen levels in regulating initiation of DNA repli-
cation at the ori-sequences has been observed to take influence
as early as 3 min of the exposure time [64]. For preventing re-
Fig. 3 Oxygen controls DNA replication: low oxygen levels decrease
ATP synthesis and reduce activity of ribonucleotide reductase thereby
decreasing dNTP (mainly dCTP) production. RPA expression and bind-
ing to DNA is reduced, and transcription factors (DREF/ZBED1) that
accumulate replication proteins bind less efficiently to DNA under low
oxygen. These changes along with “as yet unidentified proteins” cause
reduced DNA unwinding and reduced DNA replication. In contrast, the
events observed in low oxygen are reversed in optimal oxygen levels,
restoring protein–DNA interactions, modulating requisite phosphoryla-
tions as seen on RPA-70, RFC-37, MCM2, or de-phosphorylation of LTA
at Ser 120 & 123, and causing increased DNA replication
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replication and ensuring coordinated synthesis of DNA (origin
firing), the transition from pre-replication to replication com-
plexes is essential. Some of the proteins involved in regulating
this transition respond to oxygen in such a way that a permis-
sive oxygen level allows this transition (Fig. 3). Origin-firing
follows phosphorylation of MCMs, Cdc6, and Cdt1 by S
phase cyclin Cdks, association of RPA, Cdc45 and consequent
unwinding of DNA followed by primer synthesis by
Polymerase-α. Interestingly, low levels of oxygen prevent
the transition from pre-replication to replication complex,
possibly through one or more proteins in the complex [64]
(Fig. 3).
The study conducted on the Simian Virus 40 origin of
replication in CV1 cells by Riedinger et al. elucidated the
presence of assembled replication origins in hypoxic cells
(0.02 to 0.2 % pO2) [64] (Fig. 4). Interestingly, a synchronous
initiation of replication was observed within 3 min of the
process of reoxygenation of these hypoxic cells [64]. This
observation clearly suggests a direct involvement of cellular
oxygen in regulating the process of initiation of replication. In
this study, the authors speculated presence of an oxygen-
sensing mechanism and possibility of oxygen-regulated tran-
scription factors in the regulation of proteins involved in DNA
unwinding and initiation of replication [64]. Extending this
study, Riedinger et al. identified that the T-antigens, 34 kDa
RPA subunit, topoisomerase I, 48 kDa primase subunit,
125 kDa pol delta subunit, and 37 kDa RFC subunit are
assembled at the origin of replication in hypoxic cells
(Fig. 4). However, the initiation of replication was not ob-
served [65]. Interestingly, upon reoxygenation, a significant
increase in the association of 70 kDa RPA subunit, 180 kDa
Pol delta subunit, and most importantly, PCNAwas observed
along with the initiation of DNA replication (Fig. 4). It is
important to note that these proteins did not result from de
novo synthesis given the short time frame of response to
reoxygenation [65]. The hyper-phosphorylation of RPA-34
and RFC-37 and stabilization of the DNA-protein complex
of Pol delta was observed upon reoxygenation of the hypoxic
cells. The molecular mechanism behind these observations
was not provided. However, protein sequestration, dephos-
phorylation of Ser120 and Ser123 of LTA, and binding of TFs
like AP1 and NF-Kb were proposed as likely mechanistic
links [65] (Figs. 3 and 4). Similar results were also shown
by Nikoleit et al. where an increase in the PCNA nuclear
localization was observed upon reoxygenation of the serum-
deprived T24 human bladder carcinoma cells. The lack of
nuclear-Cdc6 expression was highlighted as the critical factor
regulating the delay in the initiation of DNA replication at the
Ori sequences. On the other hand, lack of PCNA nuclear
localization and a marked decrease in the association of the
nuclear fraction of PCNA to the chromatin of the hypoxic
cells was suggested as the critical factor for inhibition of DNA
replication in cells experiencing low oxygen levels [66].
Interestingly, Riedinger et al. found that the hypoxia-induced
arrest of DNA replication and decrease in the rate of propa-
gation of replication forks at the SV40 origin sequences could
be reversed upon glucose enrichment [67]. It is suggested that
higher glucose concentration (by obviating a need for
OXPHOS) could elevate cellular oxygen levels by Crabtree
effect. Increased oxygen increases the rate of fork propagation
but could not account for increased DNA unwinding required
during initiation of replication. The mechanism responsible
for immediate entry of cells into replication upon release from
hypoxia remains unknown. However, oxygen may execute
some immediate effects by controlling the binding of proteins
responsible for replication to DNA. This speculation seems
reasonable since redox-dependent binding of RPA to DNA
has already been demonstrated [59].
The MCM group of proteins is emerging as newly identi-
fied targets of oxygen. MCM 2-7 are helicases responsible for
DNA unwinding and phosphorylation of MCM2 by Cdc7 is
essential for its helicase activity [68, 69]. Investigation of
reoxygenation of T24 cells revealed that MCM2 association
with Cdc7 increases after reoxygenation and this may be
responsible for MCM2 phosphorylation, thereby activating
its helicase activity [69] (Figs. 3 and 4). In reoxygenated cells,
since MCM proteins exist at higher levels than required for
their function, Hubbi et al. hypothesized that these proteins
may be involved in functions other than DNA unwinding [70].
Indeed, it was found that cytosolic MCMs have a role in
controlling HIF1α levels by interacting with them, and in
situations requiring high HIF1a levels, MCM levels are re-
duced. MCM3 was observed to mediate the inhibition of
HIF1α trans-activation along with inducing the HIF1α
ubiquitination in a proline hydroxylation-dependent manner
[70]. Thus, MCM3 serves as an important modulator of
HIF1α functions and probably helps in overcoming the inhi-
bition of DNA replication via a HIF1α-dependent
transcription-driven mechanism. Therefore, MCM proteins
might have the potential to serve as the reciprocal regulators
of oxygen levels in cells. A moderate level of ROS accumu-
lation is essential for several signaling activities such as cell
proliferation and for cancers to accumulate multistep mu-
tations [36] that often disobey proof-reading mechanisms.
However, it has also been argued that too much ROS is
dangerous even for the cancer cells, and that antioxidant
systems in these cells are often advantageous [71]. Clearly,
ROS accumulation is dangerous even in cancer cells, since
it can cause DNA and protein damage that specifically stalls
the replication processes. It may be interesting to observe
how DNA replication rate correlates with the changing
ROS environment at the origin and homing of metastatic
cancer cell. Taken together, these findings suggest that a
direct effect of oxygen level on DNA replication machinery
is tightly regulated in mammalian cells via unidentified
molecular pathways.
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4 Cellular oxygen regulates the progression of cell cycle
Cell cycle progression consists of an ordered and stringently
regulated series of events undertaken by a cell to ensure error-
free and regulated division. Each phase is characterized by
synthesis, accumulation, and degradation of regulatory pro-
teins called cyclins, which associate with their catalytic part-
ners the “kinases.” Cell cycle perturbations are important for
oncogenic development. Oxygen participates in normal cell
cycle functioning by ensuring adequate energy generation
through regulation of OXPHOS [72]. The generation of oxy-
gen radicals (ROS) in hyperoxic or hypoxic cells shows
regulatory effects on cell cycle and suggests that its progres-
sion might be an oxygen-regulated process. In addition, a
change in the level of HIF proteins in response to oxygen
alterations regulates the cell cycle. In fact, the production of
ROS and stabilization of HIFs are the major oxygen-governed
processes that regulate the cell cycle. Cell cycle alters with a
wide spectrum of oxygen availability termed as anoxia, hyp-
oxia, and hyperoxia and thus reflects a compelling role of
oxygen in the cell cycle process. Oxygen seems to cooperate
with the cell cycle machinery as its complete absence (or
anoxia) results in arrest of the cell cycle progression in various
phases (Fig. 5). Since cell cycle requires energy and OXPHOS
is the major pathway of ATP generation, it seems reasonable
that absence of oxygen should immediately arrest cells due to
the cessation of OXPHOS. However, the study of anoxia-
mediated cell cycle arrest in organisms like Drosophila
melanogaster , Caenorhabditis elegans , and Danio rerio
shows that the cells progress through the initial phases of cell
cycle and the arrest is observed during the middle phases of
the cell cycle [73, 74] (Fig. 5) Moreover, the phase in which
cells get arrested is not the same but rather varies between
different organisms. The embryos of D. melanogaster were
Fig. 4 Oxygen promotes assembly of replication machinery and origin
firing: under low oxygen, assembly of incomplete DNA replication
machinery including Pol-δ125, RFC-37, Top-1, and RPA-34 proteins
causes replication to remain arrested. Upon progressive increase in oxy-
gen levels, the minimal or complete DNA replication machinery is
assembled as association of PCNA, RPA-70, Pol-δ180, and others occurs,
but DNA replication remains arrested. Further increase in oxygen levels
induces phosphorylation of members of replicationmachinery and causes
origin firing and DNA replication
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found to show cell cycle arrest during all phases of the cell
cycle except anaphase [75]. In contrast, the anoxia-induced
arrest of the mitotic cycle was not observed in the zebrafish
embryos. Recently, microRNAs such as microRNA-16-1 and
microRNA-15a were found to target the 3′UTR of the
cyclinD1 in turtles, resulting in the regulation of the cellular
expression in cells exposed to anoxia [76]. These observations
suggest that during anoxia, specific molecular mechanisms for
achieving cell cycle arrest are activated and it appears that
these pathways are essentially different from those activated
during hypoxia exposure (Fig. 5). It is important to observe
that anoxia-induced cell cycle arrest occurs in different phases
in different species of Drosophila and zebrafish. This indi-
cates that cellular response to anoxia is a process which is
continuously evolving with different species. This is impor-
tant, since it is clear that anoxic cells do not complete the cell
cycle but rather get arrested. Oxygen appears to be an indis-
pensable molecule for the cell cycle progression. Extensive
research has centered on a physiologically common form of
oxygen fluctuation, i.e., its shortage or hypoxia, yet from the
standpoint of 21 % oxygen as physiologically normal, a
number of organs and tissues function under hypoxia. How-
ever, a quantitative measure of the percentage and duration of
oxygen deprivation better describes biologically relevant hyp-
oxia. The cell cycle is affected under oxygen deprivation, and
several reports suggest that HIFs and ROS mechanistically
govern the arrest or progression of the cell cycle.
Role of HIF in oxygen-mediated regulation of cell cycle
progression Oxygen shortage utilizes the transcriptional ac-
tivity of HIFs to regulate cell cycle progression. Accumulation
of HIF1a during hypoxia correlates with cell cycle arrest [77]
(Fig. 5). HIFs are not known to directly regulate cell cycle
progression and are found to function by upregulating classi-
cal cell cycle inhibitors like p21 and p27. However, there
seems to be some dissent on how p21 and p27 are induced.
While HIF1α induces p21 and p27 in primary differentiated
cell types [78], a negative correlation exists in case of U2OS
cell lines [79]. In normoxic NIH3T3 cells, overexpression of
another isoform HIF2α (in addition to HIF1α) arrests the cell
cycle in the G1 phase [80]. This indicates that HIF stabiliza-
tion, even under normoxia, is sufficient to induce cell cycle
arrest. As with HIF1α, the induction of p21 and p27 by
HIF2α remains debatable in the different cell types studied.
Despite the disagreement on the exact role of HIFs in p21 and
p27 induction, reports show a predominantly G1-phase cell
cycle arrest related to HIFs [78, 79]. Although commonly
involved, p53 is not necessary for p21 induction as other
proteins induced during hypoxia such as SP-1 may activate
p21 [80]. HIFs are also known to affect Retinoblastoma (pRB)
pathway and cyclins as a mechanism to induce cell cycle
arrest in hypoxic cells. In the hypo-phosphorylated state,
pRb sequesters the E2F-family of transcription factors [81,
82]. Since E2F1 activates several cell cycle promoting genes,
its sequestration causes cell cycle arrest. Upon stimulation by
growth factors, a series of phosphorylation events on pRb
occur preventing pRb-E2F binding and associated cell cycle
progression. These phosphorylations are carried out by several
cyclin-Cdk kinases upon transition from one phase to another.
HIF1a binds to cyclin D1 promoters in A549 pulmonary cells
and results in transcriptional repression and downregulation of
cyclin D1 (Fig. 5) [83]. In fact, a decrease in HIF1a level
seems to correlate with increase in cyclin D1 and cyclin E
levels. Reciprocally, cyclin levels have been reported to alter
HIF expression or stability in the acinar growth model (of
epithelial morphogenesis). Here, cyclin E dysregulation was
reported to induce HIF1α expression [84]. On the other hand,
cyclin E may cause increased HIF1α degradation by increas-
ing prolyl hydroxylase expression through the VHL pathway
[84] (Fig. 5). It seems that in order to let cells adapt to the
hypoxic environments, HIFs cause cell cycle arrest in cancer
cells. In contrast, the other facets of HIF activation on metab-
olism, cell survival, and angiogenesis seem to promote cancer
progression, there are other players including ROS that regu-
late oncogenesis and metastasis.
Role of oxygen in ROS-mediated cell cycle arrest The pro-
gression of the cell cycle is affected by levels of ROS in a cell.
In mitochondria, oxygen being the terminal electron acceptor
produces H2O as the major and H2O2 as the minor end
product. In cells with low or high exposure to oxygen, the
ROS production via the mitochondrial pathway may increase
[85]. Early insights into ROS-mediated growth factor re-
sponse came through studies on the platelet-derived growth
factor (PDGF) receptors and epidermal growth factor (EGF)
receptors on rat vascular smooth muscle cells and A431
epidermal carcinoma cells, respectively. It was reported that
growth factor stimulation caused mitochondrial ROS genera-
tion in the form of H2O2 [86, 87]. The antioxidant catalase
abolishes ROS-mediated phosphorylation of tyrosine in vari-
ous proteins, including EGF receptor, PhospholipaseC1γ, and
MAPK-stimulated pathways [88] (Fig. 5). Mitochondria act
as the source of ROS upon growth factor binding, indicating
that oxygen is not only essential to generate energy through
OXPHOS but is purposely used as a precursor for ROS
production and hence growth factor signaling. Supporting
evidence indicates that human and rat fibroblasts progressive-
ly accumulate ROS upon cell cycle advancement [88], further
emphasizing the role of oxygen as a signalingmolecule during
cell cycle. Recent reports suggest that ROSmight be produced
as a strategy to promote the cell cycle progression. For this
reason, in situations such as hypoxia where ROS levels are
likely to be altered, other ROS-generating mechanisms such
as NOXs are employed [89]. It may be argued that the mito-
chondrial ROS produced during growth factor binding is
merely a by-product but not an active participant in cell cycle
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progression. However, other non-mitochondrial mechanisms
of producing ROS are activated under oxygen alteration.
These include several NADPH oxidases (NOXs) which are
present on the cell surface and catalyze the production of
H2O2 [71, 90] (Fig. 5). Utilization of NOXs for ROS gener-
ation indicates that cells do not exclusively rely on mitochon-
drial ROS (the levels of which are tightly governed by oxygen
availability), but rather ensure adequate ROS buildup for cell
cycle progression through other mechanisms. Further, ROS
derived from NOXs upon growth factor binding activates
signaling pathways which promote cell division [91]. For
example, growth stimulation by EGF and PDGF activates
NOX to produce ROS [92]. The ROS activates the growth-
promoting MAPK pathway to activate cell division (Fig. 5).
Thus, oxygen can promote cell cycle by affecting ROS levels
directly through the mitochondria or indirectly through NOX.
It is also important to note that oxygen can induce or suppress
ROS production through transcriptional changes by HIF1a
proteins [21–23], thus regulating cell cycle progression. In
addition to acting as a signaling molecule during the cell cycle
progression, ROS has been reported to directly affect accu-
mulation of cell cycle proteins [89]. The restriction point in G1
phase of the cell cycle is known to be the commitment step
towards cell division. Growth factor signaling during G1
phase governs whether a cell undergoes division or not. In
fact, during G1 phase, it seems a particular level of ROS helps
pass the restriction point. Interestingly, it has been observed
that levels of ROS alter synchronously with the cell cycle,
steadily increasing from G1 and declining after mitosis [89].
The role of ROS is supported by the observation that antiox-
idant treatment on fibroblasts can cause late G1 phase arrest
characterized by increased cell size. Interestingly, arrest occurs
despite of active cyclin-cdk4/6 and cyclinE-cdk2 kinases and
hyper-phosphorylated pRb [89]. The antioxidant quenching
leading to arrest elucidated an interesting role of ROS. ROS
causes transition from G1 phase by promoting cyclin-A accu-
mulation and hence cell cycle progression. ROS achieves this
by inhibiting the Cdh1 specificity factor, and hence preventing
APC-mediated ubiquitination of cyclin-A [89] (Fig. 5). How-
ever, upon antioxidant-mediated quenching of ROS, the ROS-
Fig. 5 Oxygen controls the cell cycle: complete absence of oxygen
causes cell cycle arrest in several species in a phase-specific manner.
The arrest during anoxia is also mediated by microRNAs like miR16-1
andmiR15-a. Low oxygen causes reduction in the levels of cyclin D1 and
cyclin E throughHIF1α, whereas HIF1α itself is negatively controlled by
cyclin E through the prolyl hydroxylase. Accumulation of cyclins causes
pRb hyper-phosphorylation and thus the cell cycle progression. ROS
produced by mitochondria or NADPH oxidases/DUOX2 is induced
through (1) growth factor signaling or (2) hypoxia. This causes cell cycle
progression through MAPK pathway or by inhibiting Cdh-1-mediated
cyclin-A degradation. High levels of oxygen cause S or G2/M phase cell
cycle arrest which is primarily mediated by p21
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mediated Cdh1 inhibition is lost, and cyclin A gets
ubiquitinated and degraded [88]. Thus, oxygen helps pass
the restriction point by affecting ROS generation through
OXPHOS. Similarly, antioxidant N -acetyl-L-cysteine (NAC)
administered to mouse embryo fibroblasts shows a delay in
G1/S phase transition, decreased cyclin D1 level, and about
three to four times higher p27. This correlates with reduced Rb
phosphorylation and thus a delay in cell cycle progression
[93]. Considered together, the effect of oxygen seems to
promote cell cycle through high, but physiological levels of
ROS that are not obligatory, but essential. It remains an
interesting question as to how some cancer cells, while utiliz-
ing ROS for boosted cell cycle progression, may also become
metastatic. To further surprise, high ROS proves to be tumor
suppressive [71]. A plausible explanation is that cells display a
fine tuned and graded response to ROS levels, and may
change behavior based on the duration of ROS exposure.
Further research is warranted to understand ROS and cell
cycle progression as promoters or repressors of cancers and
metastasis.
The alteration in oxygen levels can also affect proteins
which control the cell cycle, including p21, p27, p53, and
pRb. Since oxygen can also influence ROS production, it is
important to understand the interaction of these proteins with
ROS. The ROS generated through PDGF-induced NOX4 and
DUOX2 promotes pRb phosphorylation and thus cell cycle
[92]. However, upon the knockdown of NOX4 and DUOX2,
the levels of p53 and p21 increase, causing cell cycle arrest. A
simultaneous knockdown of NOX4/DUOX2 with either p21
or p53 abolishes this arrest. This finding introduces another
mechanism of ROS suppressing p53 and/or p21 accumulation
and hence promoting cell cycle. But high levels of oxidative
stress (like ROS) can activate p53/p21 as part of DNA damage
response and contradict the findings [94]. The antagonistic
choice between promoting cell cycle and causing DNA
damage-mediated arrest may depend upon ROS concentration
in the cells. In summary, oxygen levels regulate ROS produc-
tion through several mechanisms, which influence both cell
cycle progression and arrest (via DNA damage). This may be
a strategy to ensure that only those cells capable of handling
high ROS levels are selected to enter the cell cycle.
Hyperoxia and the cell cycle Hyperoxia and hyperbaric oxy-
gen (HBO, higher than atmospheric pressure of oxygen), are
usually non-physiological conditions (considering 21 % oxy-
gen and 1 ATA as physiological levels) and can cause cell
cycle changes. The effect of hyperoxia and HBO on cell cycle
progression is well studied. Cell cycle changes are observed
when prostate cancer cells are exposed to elevated concentra-
tion and pressure of oxygen. When exposed to 100 % oxygen
at 6 ATA for 1.5 h, the G1/S phase senescent cells enter S
phase and eventually arrest in G2/M-phase in a pressure-
dependent manner [95], showing that pressurized oxygen
can stimulate cell cycle progression although the mechanism
of G2/M phase arrest is unknown. Human bronchial smooth
muscle cells are observed to undergo the S phase arrest in
hyperoxic conditions [96] (Fig. 5). In this study, where two
different levels of oxygen (95 and 40 %) were administered
with respect to room air, 95 % oxygen lead to decrease in cell
proliferation within 24 h and reduced DNA synthesis to about
7 %. In the background of insignificant apoptosis, it was
reported that the number of cells in G1 phase was decreased
and instead arrested in the S phase by 72 h of exposure [96].
p21 also plays an important role in cell cycle arrest under
elevated oxygen levels. It was observed that p21 levels remain
constant in cells exposed to 40 and 21 % oxygen but are
significantly increased in the cells exposed to 95 % oxygen
(48 h) [96]. In this study, high levels of p53 expression were
observed only around 72 h post-exposure [96]. In another
study using 95 % oxygen on two adenocarcinoma cell lines
Mv1Lu (p21 null) and A549, it was shown that A549 cells
expressing p21 were arrested in the G1 phase of the cell cycle
[97] (Fig. 5). Another school of thought suggesting that a drop
in ATP levels could bring about the observed arrest was
refuted by Rancourt et al. by providing evidence that ATP
levels in hyperoxic and normoxic cells were comparable after
48 h of exposure. It was also observed that G1 arrest is
transient and that the cells begin to move towards S phase
after prolonged exposure to elevated oxygen [97].
Since p21 causes cell cycle arrest by binding Cdks and
PCNA through its two binding domains, studies were carried
out to elucidate the binding of p21 to Cdks and PCNA under
elevated oxygen. It was shown that the oxidative stress did not
abolish these binding activities of the two p21 domains and
thus p21 retains its activity of sequestering Cdks and PCNA to
bring about cell cycle arrest [98]. Despite these findings, some
disagreement remains on whether p21 (which is a known
target of p53) is solely dependent upon p53 for its expression
during exposure to elevated oxygen. In A549 and HCT116
cell lines, p53 is not required for p21 induction during elevat-
ed oxygen. In contrast, H1299 cells, which were transfected
by p53 cDNA constructs and exposed to 95 % oxygen,
showed a p53-dependent expression of p21 [98]. Transfection
of p53 in H1299 cells (p53 null) resulted in about sevenfold
increase in p21 induction, which caused more cells to be
arrested in G1 phase compared with p53-deficient cells
arrested in S and G2 phases [98]. It was shown that p53-
dependent p21 induction is responsive to elevated oxygen
but other inhibitors like INK4, Cip/Kip, and Rb are not
influenced. In alveolar cells, it was seen that p53-deficient
cells do accumulate p21 but it took about 84 h for the p21
levels to reach levels comparable to p53Wt cells [99]. It must
be mentioned that p21 has otherwise been established to be
independently expressed by TGF-β and IL-6 induction inde-
pendent of p53 [100, 101]. It is likely that p21 is induced in a
less efficient manner by an oxygen-modulated factor, other
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than p53, e.g., SP-1 [102]. The cell cycle is a combined
outcome of diverse molecular processes which involve direct
and indirect intervention of oxygen. Thus, oxygen is emerging
as a major molecule regulating the cell cycle through HIF1a
and ROS, with implications of cell cycle dysregulation in
disease.
5 Effect of cellular oxygen on protein folding
The native protein conformation is necessary for proper func-
tion and nonnative, unfolded proteins may deleteriously ag-
gregate with other proteins in a cell. A number of physical,
chemical, and biological stresses are capable of affecting a
protein's native conformation by altering the physical or bio-
chemical milieu surrounding it. A growing body of research
indicates the presence of oxygen-sensitive mechanisms that
affect protein conformation resulting in significant implica-
tions in cardiovascular, neural, and cancer disease models
[103]. Through some indirect mechanisms oxygen may affect
protein folding in a reversible way; the incorrectly folded
proteins under a particular oxygen level can undergo correct
folding when introduced in an environment of different oxy-
gen availability [104, 105]. The endoplasmic reticulum (ER)
is crucial for protein folding and changes in cellular oxidative
potential trigger the unfolded protein response (UPR) in the
ER. The presence of chaperones like Grp78/BiP in ER facil-
itates protein folding during unstressed or mildly stressed
conditions. BiP plays several roles based on its localization
including signaling and apoptotic roles [106]. However, when
present in ER, BiP interacts with the hydrophobic residues of
nascent or misfolded proteins and facilitates their correct
folding. Oxidative stress causes extensive protein misfolding
which requires increased levels of BiP for refolding these
proteins. Studies indicate that under oxygen fluctuations
which generate oxidative stress, BiP levels are altered. For
example, proteomic analysis shows that administering 5 %
oxygen to cells increases the levels of BiP [107] (Fig. 6).
Clearly, increased levels of BiP points to a homeostatic re-
sponse evoked by hypoxic cells. A similar study in which BiP
is induced by BiP inducer X (BIX), cells under ER stress
survive better than those lacking BIX [108], showing that
hypoxia-mediated BiP overexpression protects cells from
UPR (Fig. 6). In contrast to rescuing proteins, there exist
situations when acute stress-induced apoptosis benefits the
organism, which otherwise can lead to diseases such as cancer
[108]. It is for this reason BiP induction is not observed in
cells exposed to less than 1 % oxygen (Fig. 6). BiP is also
induced by the knockdown of another ER protein ERp57,
which undertakes redox-dependent protein folding [109] and
BiP induction results in protection of cells from hyperoxia-
mediated apoptosis. At transcriptional level, BiP expression is
controlled by the ER-associated protein ATF6 [110]. During
ischemia, ATF6 induces BiP to protect cardiomyocytes from
apoptosis, while reperfusion (restoration of blood supply)
reverses this activation [111].
Another ER protein that links oxygen to protein folding is
oxygen-regulated protein 150 kDa (ORP150). The protein
was initially identified in the ER of mouse astrocytes subject-
ed to hypoxia [112]. ORP150 is produced by de novo protein
synthesis exclusively under oxygen deprivation and its acti-
vation cannot be mimicked by other stresses like heat, H2O2,
and CoCl2 [112]. The chaperoning activity of ORP150 is now
identified [113]. Indeed, several studies establish ORP150 as a
cytoprotective agent which reduces ER stress [114, 115] and
possibly apoptosis in hypoxic cells [116]. ORP150 may even
have beneficial roles in hypoxic tissues since it helps VEGF to
attain proper folding, thus increases angiogenesis and wound
healing associated with hypoxic tissues including hypoxic
cancers [117, 118]. The copper chaperone for SOD is another
chaperone which responds to oxidative stress and is thus
related to cellular oxygen. The activation of Cu/Zn SOD1
requires the delivery of copper to SOD1 and this process is
facilitated by CCS [119–121]. Copper delivery by CCS is
specific to SOD1 and not to proteins found elsewhere [119,
121]. In Drosophila , CCS null flies resemble SOD1 null flies
in terms of sensitivity to oxidative stress and show reduced
adult life span [122]. In fact, it was recently reported that
oxygen, copper, and CCS are required only for oxidation of
disulfide bonds in SOD1. Under oxygen- and copper-deficient
conditions, oxidation of SOD1 disulfide bond results in CCS-
independent activation of SOD1 [123]. The protective role of
many conventional and recently discovered heat shock pro-
teins (Hsp) has been identified in relation with cellular oxygen
changes. For example, hyperoxia-induced injury in newborn
rat lungs and A549 cells is mediated by downregulation of
Hsp27, and hyperoxia-induced apoptosis is reduced upon
Hsp27 overexpression [124]. Similarly, oxygen–glucose dep-
rivation followed by reoxygenation in N2A-neuroblastoma
cells results in a decrease in Hsp20 levels followed by apo-
ptosis. Interestingly, the overexpression of Hsp20 protects the
N2A cells from reoxygenation-induced apoptosis [125]. The
Hsp90- and Hsp70-mediated protection against hyperglyce-
mia or ischemia-induced apoptosis in neuronal cells was
observed by Leitch et al. [123] and Doeppner et al. [126,
127]. Further overexpression of Hsp90 was observed to pre-
vent the neuronal cell lysis [128], providing insight into the
cytoprotective role of these chaperones [129] (Fig. 6).
Some chaperones physically associate with HIFs and con-
trol their stability and degradation in response to varying
cellular oxygen levels. Cells lacking Hsp90β show delayed
accumulation of HIF1α and induction of Hsp90/Hsp70 helps
in stabilization of HIF1α, suggesting that Hsp90 is required
for HIF1α folding [130]. Zhou et al. showed that PI3K/Akt
signaling is important for upregulating Hsp90/Hsp70
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expression in hypoxic cells and this result in preventing
HIF1α from VHL-independent degradation and correct fold-
ing of HIF1α [131]. Similarly, JNK1 also helps in HIF1a
stabilization by upregulating the expression of Hsp90/Hsp70
proteins [132]. Bcl-2 also causes HIF1α stabilization by in-
creasing the chaperone activity of Hsp90β [133]. Some VHL-
independent mechanisms of HIF1α degradation compete with
Hsp90/Hsp70 protein for binding at the NODDD and
CODDD domains of HIF1α [134]. The RACK1 and
COMMD1, for example, degrade HIF1α by competing with
Hsp90 and Hsp90/Hsp70, respectively, in an oxygen-
independent manner [135, 136]. A well-established inhibitor
of HIF1α, the Kruppel-like factor 2, exerts inhibitory activity
by disrupting HIF1α-Hsp90 association and hence disrupting
the proper folding of HIF1α [137]. Another report shows that
the VHL, which requires Fe(II) for activity, incorporates Fe(II)
through a chaperone PCBP1, in the same way as CCS and
HIF1α degradation is compromised upon PCBP1 depletion
[138]. Taken together, the reports suggest that beyond the
well-studied step of oxygen-dependent accumulation of
HIF1α, the correct folding of this protein is another regulatory
step in HIF1α signaling.
Hyperoxia induces extensive cell damage through oxida-
tive stress and as a response cells activate molecular chaper-
ones and protein degradation pathways to overcome
hyperoxia-mediated cellular damage [139] (Fig. 6). Hsp70
overexpression results in hyperoxia-induced cytoprotection
[140] and inactivation of HSPs in hyperoxic fibroblasts results
in cellular injury, high membrane lipid peroxidation, and
decreased ATP levels [141]. Similarly, expression of BiP
protein and Hsp27 protect against hyperoxia-induced stress
[124, 142]. However, a recent report shows that hyperoxia is
insufficient to trigger UPR and does not activate ER stress
receptors ATF6, IRE1, and PERK [143] (Fig. 6). In addition to
indirectly controlling protein folding, oxygen may directly
control protein conformation. Gogna et al. made a few impor-
tant observations relating oxygen-dependent function of p53.
It was reported that oxygen levels can directly control the
conformation of p53 such that hypoxia induces a mutant p53
conformation [105]. Further, introduction of p53 in wild type
conformation could promote the misfolded p53 to be correctly
folded implying a chaperone-like activity of p53 [105]
(Fig. 6). To further support the novel finding, this group
showed that while hypoxia caused conformation-based p53
Fig. 6 Oxygen controls protein folding: the unfolded protein response
(UPR) is triggered to correctly fold proteins upon stress. Very low oxygen
levels fail to induce UPR as BiP expression is reduced, thereby causing
accumulation of misfolded proteins and cell death. Under recoverable,
low oxygen levels increased BiP expression aides correct protein folding
and promotes cell survival. Low oxygen also causes increased Hsp90 and
Hsp70 expression through P13K, Akt, JNK1, and Bcl-2 pathways, there-
by chaperoning HIF1α and promoting its association with HIF1β,
resulting in its nuclear translocation. Under high oxygen, it is unclear if
ATF6, IRE1, and PERK induce BiP to correctly fold proteins. However,
Hsp70 and Hsp27 expression aids correct protein folding and promotes
cell survival
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activation, elevated oxygen concentration and pressure could
cause tumors to regress [104].
In conclusion, many molecules respond to oxygen levels
and function as oxygen-dependent chaperones. These protein
either directly affect protein folding or they induce other
downstream chaperones. However, much needs to be
researched upon the generic mechanisms or paradigms that
dictate the folding of proteins in response to oxygen. It is an
interesting area of therapeutic intervention and drug develop-
ment where oxygen-deficient tumor areas can be targeted for
oxygen therapies to restore protein-folding activities.
6 Oxygen controls cellular apoptosis
Oxygen supply through tissue vasculature defines the region
in which cells can grow as oxygen limits the potential of cells
to generate energy through OXPHOS. The vasculature is
often dynamic causing alterations in oxygen levels, thus af-
fecting cell survival. The tumor vasculature is more dynamic
than normal tissues, often causing sudden changes to oxygen
supplies within the tumors and probably influencing cancer
cell survival and selection. Cells that encounter mild oxygen
fluctuations may undergo cell cycle arrest (Fig. 7); however,
acute stress is lethal and necessitates programmed cell death.
Cancer cells not only adapt to evade cell death upon severe
oxygen-based stress but often gain selective advantage by
activating survival cascades, preventing apoptotic programs
and gaining metastatic abilities in order to “find” favorable
conditions. This has also led to the suggestion that metastasis
might be an antioxidant strategy to favor the growth of cancer
cells in these environments [71]. Interaction of oxygen with
several intracellular signaling pathways determines whether a
cell is fit to survive or not under oxygen fluctuation. These
interactions are mediated by apoptosis-associated proteins,
their posttranslational modifications and calcium signaling.
Major signaling pathways including NF-κb, Wnt/β-Catenin,
Notch, and PI3K pathways are involved in the oxygen-
mediated control of apoptosis [144–147]. Posttranslational
modifications such as acetylation, ubiquitination, and phos-
phorylation of apoptosis-associated proteins may also link
oxygen fluctuations with programmed cell death [148–150].
Moreover, calcium-dependent phosphorylation of
antiapoptotic proteins Bcl-2 and Bcl-xl in nuclei has also been
shown to be effected by oxygen fluctuation [150] (Fig. 7).
Oxygen response is thus ubiquitous and evolution of such a
comprehensive system to control cell death could be an early
event that has been fine-tuned to benefit complex organisms.
Oxygen fluctuations often cause accumulation of high
levels of ROS which is lethal to a cell [151–153] and in fact
inhibition of ROS correlates with a reduction in cell death
[154, 155]. Since ROS can cause DNA damage and malignant
transformations, stress-induced ROS initiates apoptosis. For
example, the UPR in the endoplasmic reticulum triggers ROS
which mediates apoptosis [156, 157] (Fig. 7) and has been
shown to activate intrinsic mitochondrial death pathways
[153, 156]. Even low glucose and oxygen can induce apopto-
sis through UPR-dependent ROS generation [158]. The
sources of ROS may include the NOX family of NADPH
oxidases [159, 160] in addition to the mitochondria [161]
(Fig. 7). In fact, Ferber et al. showed that inhibition of over
2,700 mitochondrial genes leads to altered ROS [162] and cell
death is brought about by mitochondria-derived superoxide
radicals [163]. A cross talk between ROS, mitochondria, and
NOXs also exists [164]. The role of mitochondria is impera-
tive as it links oxygen utilization (through OXPHOS) with
apoptosis (commonly initiated in the mitochondria). Mecha-
nistically, the electron transport chain (ETC) leakiness in the
mitochondria is a source of ROS, which is also influenced by
oxygen levels [165]. It is believed that irreversible mitochon-
drial permeability and consequent cytochrome c release com-
mit cells to undergo apoptosis. However, transient changes of
the mitochondrial complex appear to drive periodic increases
in superoxides called “superoxide flashes.” These may be the
markers indicating apoptosis or early events during apoptosis
and even convergence points where signals for apoptosis
integrate [166, 167]. Additionally, cytochrome c in its oxi-
dized form is a superoxide scavenger and its loss during
ischemia majorly determines ROS production during heart
ischemia studies [168]. Since ROS can influence pathways
such as ERK1/2 [155], PI3K-Akt [169], and AMPK [170] to
modulate apoptosis, it would be interesting to link the tempo-
ral aspects ROS generation with these pathways which elicit
apoptosis.
HIFs exert a protective role on cells, for example through
regulation of the expression of genes like erythropoietin,
suppression of TGF-β signaling, and expression of survivin
and Bcl-2 [171–173] (Fig. 7). The negative regulators of
HIF1α increase cell death sensitivity [174]. Several physio-
logical and pathological conditions indicate that HIF1α exert
protective roles. Induction of HIF1α through mTOR in the
developing rat brain correlates with increased survival [175].
In fact, stabilization of HIF1α in epithelial cells causes sup-
pression of Fas-associated death domain [176]. Conversely,
suppression of HIF1α increases susceptibility to apoptosis as
seen during simultaneous inhibition of GSK-3β and CDK1
which help overcome resistance to apoptosis in hypoxic cells
[177, 178]. Cells are also more susceptible to radiation-
induced cell death when HIF1α is knocked down [179].
HIF1α expression during ischemia–reperfusion also displays
beneficial roles in cardiomyocyte, post-ischemic renal injury,
and hyperthermic preconditioning [180–182]. Emerging tar-
gets of HIF1α, such as the ARC (apoptosis regulator with
caspase recruitment domain) may also be cytoprotective as
they exert anti-apoptotic activity during hypoxia [183]
(Fig. 7). An interaction between ROS and HIFs is also capable
196 Cancer Metastasis Rev (2014) 33:183–215
of controlling cell death during hypoxia and in fact ROS can
stabilize HIF1α [184], while HIF1α can control mitochondri-
al activity during hypoxia [185] through events such as sub-
unit switch in cytochrome c, miR-210 expression, and others
[178] (Fig. 7). HIF1α responds to diverse agents such as UVB
radiation damage in connection with ROS [186].
Oxygen fluctuations are cellular stressors which can acti-
vate p53, the well-known modulator of apoptosis during
stress. Recently, the role of p53 in oxygen-dependent apopto-
sis has been highlighted (Fig. 7). p53 fusion protein targeting
to hypoxic non-small cell lung cancer resulted in apoptosis
[187]. p53 can utilize the signaling from ROS inducing pro-
teins such as p66Shc and cytochrome c to generate apoptotic
signals [188, 189]. Evidence suggests that interactions be-
tween p53 and mitochondria may be required for inducing
apoptosis as seen in neonatal ischemic brains [190]. In partic-
ular, inhibition of p53 association with mitochondria using
pifithrin-μ is a neuroprotective strategy, as it prevents cyto-
chrome c release, reduces oxidative stress, and consequently
reduces the lesion size in ischemic brain [190]. A critical role
of p53 in apoptosis upon oxidative stress is implied by the
functional redundancy of p53; certain mutations in p53 are
tolerated due to activation of alternate mechanisms. Function-
al p53 induces a caspase-dependent apoptotic response while
mutantp53 induces caspase-independent, AIF-dependent re-
sponse in neuroblastoma cells under hypoxia-mimetic agent
CoCl2 [191]. Functional p53 is also reported to induce AIF
through caspase 2 [192]. Along with these well-known tar-
gets, new pro-apoptotic targets of p53 like PERP and Siva
have been reported to be activated during ischemia [189, 193].
It is clear that oxygen–p53 connection has an indispensable
role in apoptosis and they function in close association with
the mitochondrial pathways (Fig. 7).
Hyperoxia is also reported to be well-connected to apopto-
sis. The common proteins involved in apoptosis include Bcl-2
family members of apoptosis-signaling proteins of which
BAX, BID, BAK, and BAD are pro-apoptotic while Bcl-Xl
and Bcl-2 are anti-apoptotic. Hyperoxia is deleterious to cells
Fig. 7 Oxygen controls cellular apoptosis: high and low oxygen levels
promote cell survival or death pathways, respectively. Low oxygen levels
promote survival through HIF1α-mediated gene expression and cell
death through p53-mediated pathways. High oxygen induces pro-survival
pathways through increased levels of anti-apoptotic proteins, ROS
scavenging, cell cycle arrest, and inactivation of pro-apoptotic pathways.
High oxygen also induces increased pro-apoptotic proteins, inactivation
of anti-apoptotic proteins, and nuclear influx of calcium. The outcome is
decided by the strength of the two opposing signals
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as it induces ROS production, although mitochondrial ROS
may be dispensable [194]. For example, exposure of neonatal
rat lung cells to hyperoxia induces apoptosis by activation of
pro-apoptotic protein BAX [195]. Similarly, hyperoxia treat-
ment (100 % O2) given during perinatal hypoxia–ischemia
leads to BAX-mediated neuronal cell death [196]. During
hyperoxia, posttranslational modifications such as phosphor-
ylation of Bcl-2 and Bcl-xl can result in loss of their anti-
apoptotic potential [197] (Fig. 7). Investigation on whether
ROS acts upstream of death pathways or is produced as a
result of mitochondria permeability led to the conclusion that
ROS can indeed initiate apoptotic signaling through BAX in
hyperoxic cells [198]. In alveolar epithelial cells, oxidative
stress activates BAX and BAK for cell death as SOD overex-
pression or loss of BAX and BAD can prevent apoptosis
[199]. Cells overexpressing anti-apoptotic Bcl-2 have reduced
mitochondria-mediated apoptosis and higher antioxidant com-
pounds during hyperoxia [200]. In addition to ROS, nuclear
calcium influx has been reported during hyperoxia of cortical
neurons, which specifically affects CREB protein-mediated
transcription of pro-apoptotic genes [201]. These reports in-
dicate that hyperoxia, in general, has pro-apoptotic roles.
However, the cell does not always succumb to hyperoxia-
mediated apoptosis. In fact, inhibitory posttranslational phos-
phorylation can prevent apoptosis. For example, during
hyperoxic acute lung injury IL-6 induces phosphorylation of
BAX, rescuing apoptosis via PI3K/Akt-mediated pathway
[202]. Also, overexpression of hemeoxygenase-1 can prevent
cell death through increased production of carbon monoxide,
which inhibits apoptosis in endothelial cells by decreasing
caspase 3/9 activation and cytochrome c release [203]. NAC
can prevent the ROS-mediated activation of JNK pathway that
induces apoptosis in type II alveolar epithelial cells by scav-
enging ROS [204]. Another radical scavenger, thioredoxin 1,
exerts a cytoprotective role by, in part, upregulating Bcl-2
protein [205] (Fig. 7). Cells may use these proteins to restore
cellular homeostasis during hyperoxia. Although p53 is pro-
apoptotic, it can also activate p21 to arrest cells giving them a
chance to recover from oxidative stress. p21 prevents induc-
tion of apoptosis by utilizing various mechanisms; while p21,
p53, and BAX seem to be induced under hyperoxia, p21-
deficient mice showed less survival [206]. The cytoprotection
by p21 may be due to reduction in proliferation, increase in
pro-survival proteins, or induction of senescence [99]. In fact,
p21 overexpression causes a delay in the loss of anti-apoptotic
proteins Mcl-1 and Bcl-Xl and protects against hyperoxia
[207]. One investigation has suspected the role of p21 (with
deleted NLS) as an oncoprotein by showing that its cytoplas-
mic localization, possible association with mitochondria, and
p21-dependent delay in the loss of anti-apoptotic proteins
exerted cyto-protective effects during hyperoxia [206]. The
same study elucidated another role of p21 that it causes
increase in BiP chaperone in ER, leading to correct protein
folding which suppressed UPR-mediated induction of apopto-
sis during hyperoxia [206]. Thus, p21 is not just an essential
mediator of cell cycle arrest during oxygen changes, but it also
exerts cytoprotection by delaying apoptosis through numerous
mechanisms.
In summary, elevated oxygen levels appear to induce ROS-
mediated cell death while low oxygen promotes HIFs, in
addition to ROS generation. Recent reports have expanded
our knowledge on the mediators and effectors of oxygen-
mediated apoptotic pathways and suggest unconventional
roles of known proteins in modulating these intricate process-
es. Tumor environments, stem cells niches, pulmonary dam-
age, and cardiovascular models, among others, have provided
insights into how apoptosis can benefit or damage cells or
tissues. Aspects of physiologically low-oxygen or elevated
oxygen as well as of reoxygenation emphasize oxygen's piv-
otal contribution to apoptosis. Although both apoptotic and
survival signaling ensues upon hypoxic or hyperoxic/HBO
exposure, the relative balance might dictate the ultimate out-
come. Clearly, cancers utilize these homeostatic mechanisms
in hypoxia (through HIFs) and in a less direct manner during
elevated oxygen exposure to gain survival advantages.
7 Oxygen mediates cellular senescence
In the natural process of aging, a cell accumulates several
abnormalities of which genomic insults are noteworthy. Al-
though these abnormalities do not affect the functioning of the
cell, the division can predispose cells towards malignancies.
Senescence is a form of quiescence that preserves the func-
tional competence of cells while prohibiting their entry into
cell division. Senescence can be induced naturally due to
shortening of telomeres (called replicative senescence) or
may be induced due to high oncogene activity (oncogene-
induced senescence, OIS).
Oxygen and senescence are connected in a number of
ways. Oxygen stress is capable of cellular damage through
generation of ROS and a general disturbance of redox homeo-
stasis, both of which induce senescence. Also, since oxygen
supply can affect cellular energy balance, the rate at which a
cell divides (often limited by nutrient availability) and reaches
senescence may also be an oxygen-governed process. The
relationship between ROS and senescence was reported in
fibroblasts where oncogenes such as Ras-generated excessive
H2O2 which led to cellular senescence [208], possibly due to
growth factor signaling. Interestingly, hypoxia was found to
inhibit senescence by reducing cellular ROS levels [208].
Extending the correlation of ROS with senescence, Leikam
et al. showed that strong growth factor signaling triggers
ROS-mediated senescence [209], supporting the observation
of ROS-driven cell cycle progression (Fig. 8). These findings
support a model in which growth factor-induced ROSmust be
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present within a range to promote cell cycle. A low level of
ROS signifies absence of growth stimulus whereas an excess
of ROS signifies rapid growth, as observed during oncogen-
esis. Other studies support ROS-dependent senescence by
reporting that mitochondrial mass increases during OIS and
that interference with mitochondrial OXPHOS and electron
transport chain is sufficient to induce senescence [210]. In
addition to the mitochondria, the ROS produced by NOXs can
induce senescence by causing DNA damage [211] (Fig. 8).
Irrespective of the source of ROS, it has been shown that
antioxidants can prevent senescence in cells where ROS is
derived from mitochondria or photochemical treatment [212,
213]. In addition, inhibitory pathways that contribute to ROS
production have also been shown to reduce senescence. For
example, PTEN-mediated inhibition of superoxide production
in PI3K-mediated pathway can inhibit UVB-induced senes-
cence in human keratinocytes [214].
The hematopoietic stem cells (HSCs) residing in acute
hypoxic areas require high rates of proliferation and self-
renewal, and provide a model to study the significance of
hypoxic niches and senescence. It is emerging that hypoxia
causes decreased ROS levels in HSCs and is thus responsible
for delaying senescence. This correlation was observed by
Jang and Sharkis showing that low oxygen levels select for
primitive HSCs, and that their self-renewal ability is dimin-
ished upon introduction to higher oxygen levels during serial
transplantation in mice [215] (Fig. 8). Interestingly, ROS
utilizes the p38/MAPK pathway to cause senescence indicat-
ing a specific response of cells to oxygen levels and thus ROS
[215, 216]. In contrast to these findings, Hole et al. reported
that ROS in CD34+ hematopoietic progenitor cells promotes
proliferation [217], probably further supporting the model
where ROS levels can decide cell cycle progression or
senescence.
p53 and pRb are capable of keeping cells in a senescent
state and can function cooperatively to induce senescence.
However, whether ROS triggers p53-mediated senescence
remains unknown, although p53 utilizing ROS to induce
senescence (and apoptosis) is a known phenomenon [218].
In contrast, some studies show senescence mediated by p53
without any report of ROS change. For example, oncogenic
Ras and p53 cooperate to induce senescence, although no
ROS change was reported [219]. However, since Ras itself
is known to produce ROS for senescence [208], it is likely that
ROS plays an essential role. ROS, by causing DNA damage,
can activate ATM pathways and thus elicit p53-mediated
senescence [220–222] (Fig. 8). This is similar to activation
of p53 during telomere shortening, a situation similar to DNA
double-stranded breaks [223] (Fig. 8). Activation of several
Cdk inhibitors like p21, p15, p16, and p27 is seen during
senescence [224, 225] (Fig. 8). The role of pRb in sequester-
ing E2F family of cell cycle proteins is known, and through its
interaction with p16, pRb is involved in senescence [226].
The HIF1α protein seems relatively less studied in relation
to senescence, but reports indicate a protective role of HIF1α
on cells. For example, it was reported in primary human lung
fibroblasts that increased ROS correlated with increased
HIF1α, and the replicative life span of cells was increased
due to HIF1α-mediated telomerase induction [227] (Fig. 8).
Similarly, HIF1α seems to activate telomerase in murine
embryonic stem cells as identified by a RNAi screen [228,
229]. Also, the role of pVHL was implicated in senescence
where it was shown that pVHL pathways can function with or
without HIF1α to influence senescence [230–232].
Elevated oxygen also seems to have some relation with
senescence since high pressure (2 ATM) or concentration
(40 %) of oxygen can induce senescence in human diploid
fibroblasts [233]. Hyperoxia can reduce telomerase activity
which correlates with reduced telomere lengthening in endo-
thelial cells [234] (Fig. 8). In addition to this, hyperoxia
decreases histone deacetylase (HDAC) activity and increases
p53 and p21 levels causing the cells to enter senescence [235].
In another study using hyperoxia (70 % oxygen), ROS inde-
pendent mechanisms were reported to be responsible for
senescence [236] (Fig. 8) involving p53-mediated p21 and
pRb-mediated p16 upregulation [236].
8 Oxygen regulates cellular motility and cancer metastasis
Oxygen contributes to cell motility in a number of events
which indicate that oxygen acts like a chemotactic molecule.
The processes of HSC migration, neutrophil recruitment and
extravasation, wound healing, as well as cell invasion and
metastasis are all events where oxygen gradients guide cellu-
lar movement. Cellular motility is associated with changes in
expression of cell adhesion molecules, often described as
restoring to mesenchymal phenotypes. From the perspective
of cellular motility, the process of metastasis involves disso-
lution of the basement membrane, detachment from primary
site, and intravasation into the blood through endothelium.
This is followed by extravasation from the vessels and colo-
nization the secondary tissue, homing, and proliferation.
Many of these molecular processes are influenced by oxygen
levels.
The events in metastasis can be viewed as those occurring
at the level of tissue stroma, yet gaining support from the
complex intracellular signaling cascades. In order to sustain
these signals over the long duration of metastasis, ROS pro-
duction has emerged as a crucial strategy utilized by these
motile cells. The activation of the MAPK pathway, that is
indispensable to support cytoskeletal changes, is one such
signaling cascade activated by ROS. The long-term activation
of MAPK pathway occurs through the ROS-mediated inacti-
vation of the paxillin-associated protein–tyrosine phosphatase
(that inhibits RTK signaling), as well as direct activation of the
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PKC pathway [237]. The resulting effect of ROS is thus the
activation of RTK and PKC that maintain MAPK activity, in
effect promoting motility. Another target of ROS is PAK that
is an effector of Rac-mediated cytoskeletal remodeling. The
activity of PAK is responsible for cytoskeletal remodeling that
is utilized to gain motility and to support angiogenesis [36].
Hypoxic regions within tumors not only exploit the
cytoprotective role of HIF1α but also utilize this transcription
factor to increase the expression of metastasis-associated
genes, including matrix metalloproteinases (MMPs) [238].
In general, MMPs are responsible for the dissolution of the
basement membrane. While this is a part of normal develop-
mental processes in HSC migration, it is also the primary step
towardsmetastasis [239] implicated in several cancers, includ-
ing lung and breast tumors [240, 241]. MMP expression is
also seen in cell lines of breast, lung, pancreatic, and cervical
cancers [242]. Under hypoxia, HIF1α overexpression results
in an increase in the cellular levels of MT1-MMP in HSCs
which play an important role in regulating their migration
patterns [239]. HIF1α also regulates the gelatinase activity
of MMP-9 in breast cancer cells [240] and transcriptionally
targets MT2-MMP through HREs on its promoter [242]. In
fact, a critical balance ofMMPs and tissue inhibitors ofMMPs
seems to be disturbed during hypoxia in favor of MMPs,
which leads to an increase in invasion and metastasis potential
of hypoxic cells [243] (Fig. 9).
Cellular motility, facilitated upon transition of epithelial
cells to mesenchymal cells (the EMT transitions), is well
known during metastasis. EMT transitions include altered
expression of cell adhesion molecules—while E-cadherin is
associated with retention of adhesion, N-cadherin promotes
migration [244] (Fig. 9). Accumulating evidence shows a
potent role of oxygen in acting as a switch for EMT by
affecting HIF1α and redox environment, for example. It has
been observed that lower oxygen levels can induce EMT
transitions; however, it is surprising to note that higher oxygen
concentrations can reverse EMT transitions [244]. This obser-
vation is a phenomenon of immense therapeutic significance.
Fig. 8 Oxygen regulates cellular senescence: (top) the senescence model
of stem cell differentiation where low oxygen levels correlate with low
ROS and increased self-renewal potential. Upon increasing oxygen
levels, ROS accumulation causes reduced self-renewal and increased
senescence. (bottom) The molecular basis of low senescence in hypoxia
is based on HIF1α-dependent activation of telomerase to prevent repli-
cative senescence. High oxygen levels promote senescence by inhibiting
telomerase activity, and by ROS mediated DNA damage; the resulting
damage or shortening of DNA causes DNA damage signaling and p53,
pRb, and Cdk inhibitor-mediated senescence
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The reversal of EMT (calledMET) is seen and is characterized
by increased E-cadherin expression and decreased N-cadherin
expression along with reduced expression of pro-angiogenic
proteins like VEGF, FGF, and PDGF [244]. Thus, it is inter-
esting how complex phenotypes can be reversed by simple
alteration in oxygen levels (Fig. 9).
The Wnt/β-catenin pathway is utilized by HIF1α to signal
EMT transition as knockdown of β-catenin leads to E-
cadherin expression in human prostate cancer cells LNCaP
providing an essential link between HIF1α and E-cadherin
expression [245] (Fig. 9). However, Schietke et al. report that
lysyl oxidases, which are regulated by HIF1α during hypoxia,
are sufficient to induce E-cadherin downregulation [246]. It
remains elusive whetherβ-catenin signaling is utilized for this
downregulation. HIF1α can also cause increased expression
of transcription factors involved in cellular motility. For ex-
ample, it has been shown that Twist expression, which in turn
causes N-cadherin expression, is controlled by HIF1α and is
induced by thrombin [247] providing another example of
oxygen levels regulating cellular motility (Fig. 9).
In addition to fluctuations in oxygen levels, reoxygenation
can also affect cellular motility. For example, reoxygenation
of human pancreatic cancer cells (PANC-1) after hypoxia
causes invasion mediated by increased production of MMP-
2 [248]. Supporting evidence shows that E-cadherin expres-
sion is transiently reduced after hypoxia and reoxygenation of
human colon cancer cell lines [249] indicating a mesenchymal
phenotype. Sprague et al. observed that plasminogen activator
inhibitor-1 (PAI-1, a serine protease inhibitor) (involved in
pre-adiposite migration) [250] is upregulated and secreted
from hypoxic head and neck cancer cells 24 h following
reoxygenation [251]. The levels of PAI-1 correlate with met-
astatic ability of cells [251]. Similarly, Postovit et al. observed
that re-oxygenation promotes metastasis by lysyl oxidase's
catalytic activation [252]. These findings suggest that reoxy-
genation can promote metastasis by diverse pathways.
Fig. 9 Oxygen governs cellular motility and metastasis: high oxygen
levels induce epithelial-like phenotypes, displaying higher E-cadherin
and low N-cadherin levels resulting in low cell motility and metastasis.
Lower oxygen levels cause epithelial to mesenchymal transitions
displaying high N-cadherin, low E-cadherin, and HIF1α expression. At
a molecular level, HIF1α mediates increase in expression of N-cadherin,
decrease in expression of E-cadherin, basement membrane dissolution
through matrix-metalloproteinases (MMPs), increased expression of
Twist and Wnt/beta-catenin signaling, and causes increased cellular mo-
tility. Oxygen may reverse cell motility based on its relative levels
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These reports suggest that the movement of cells either
along or away from an oxygen gradient follow a molecular
reprogramming, mediated predominantly by HIF1α and ROS
but utilizing several downstream pathways. In fact, it has been
suggested that some of the mechanisms that drive aerotaxis
towards oxygen and nutrients in Escherichia coli are similar
to those involved in redox-driven movement during metasta-
sis [71]. As reports on oxygen-dependent motility accumulate,
our understanding of compromised cell motility during em-
bryonic development and immune activation on one hand, and
aberrant motility during cancer-metastasis on the other will
increase, thereby also opening up oxygen therapies as likely
additions to ongoing administration of drugs.
8.1 p53 and oxygen
The connection of oxygen with p53 is an example of the
extent to which oxygen impinges upon cellular mechanisms
and influences cancers. A fluctuation in oxygen levels acti-
vates p53 through posttranslation modifications by upstream
proteins. Interestingly, these posttranslational modifications
are specific for a particular form of oxygen-mediated activa-
tion (such as through ROS or HIFs). Besides this, direct
interaction of p53 and hypoxia-specific proteins (such as
HIF1α), modulation of ROS levels through p53, and even
oxygen-dependent chaperoning activities of p53 are ways by
which oxygen is linked to p53 and thus cancers. Fluctuation of
oxygen levels disturb cellular homeostasis which results in
activation of p53. Posttranslational modifications are critical
component of p53 activation and they regulate the stability,
protein–protein interactions, and transcriptional function of
p53. Several posttranslational modifications of p53 are linked
to altering oxygen levels. p53 activity is now shown to be
related to HIF1α in hypoxic cells, further the involvement of
p53 in regulation of cellular metabolisms suggests its ability to
sense cellular oxygen levels.
Since HIF1α is essential in hypoxic responses, its interac-
tion with p53 is interesting given that both these transcription
factors are involved in certain cooperative as well as antago-
nistic roles. It remains unclear whether HIF1α is necessary for
p53 activation under hypoxia [253, 254] or the hypoxic envi-
ronment causes p53 activation. HIF1α indirectly stabilizes p53
by binding to MDM2, and thereby reduces the MDM2-
mediated p53 degradation [255]. However, in agreement with
its tumor suppressive role, p53 indirectly causes degradation of
HIF1α probably to limit the pro-survival effects [255] (Fig. 10).
Under oxygen fluctuations, the accumulation of ROS
causes DNA damage and leads to a p53-mediated DNA
damage response (Fig. 10). The accumulation of ROS causes
oxidation of nucleotides and RNA damage [256, 257], while
DNA instability and compromised repair are seen under hyp-
oxia [258, 259]. Althoughmoderate levels of ROS help cancer
cells acquire new mutations, it has recently also been
suggested that cancers that activate antioxidant mechanisms
to fight ROS accumulation survive better. As a deduction,
ROS can actually help suppress tumorigenesis through an
interplay with tumor suppressor proteins including p53 [71].
Reoxygenation and hyperoxia, like hypoxia, can cause exten-
sive DNA damage which often triggers p53-mediated apopto-
sis [260, 261]. Like other stresses, oxygen fluctuations utilize
conserved pathways involving ATM, ATR, and p53 to sense
DNA damage. ATM responds to double-strand damage and
involves Chk2 while ATR gets activated by single-strand
damage and replication stalling, activating the Chk1 pathway
(Fig. 10). Under hyperoxia, the extent of p53 activation seems
to vary in different cell types. For example, in bronchial
smooth muscle cells, 95 % oxygen does not cause significant
p53 accumulation until 72 h [96], while A549 and Mv1Lu
cells under 95 % oxygen show high p53 expression and p53-
Serine15 phosphorylation [97]. The ATR pathway, but not the
ATM pathway, seems to be required for signaling initial
damage through critical p53 phosphorylations as ATM(−/−)
cells have no effect on p53-Ser15 phosphorylation [262] and
ATR alone mediates p53-Ser(-6, -15, -37, and -392) phos-
phorylations [263]. An emerging view of hyperoxia-mediated
damage suggests that ATR is initially required for DNA
damage-mediated p53 phosphorylation but sustenance of
phosphorylation status involves ATM. Another family mem-
ber of ATM/ATR called SMG-1, a RNA surveillance protein,
can also activate p53 upon DNA double-strand breaks [264].
Collectively, hyperoxia-mediated p53 activation seems to uti-
lize ATR/ATM proteins but follows a unique ATR/ATM-
mediated signaling pathway for eliciting DNA damage re-
sponse (Fig. 10).
It may appear that ROS acts upstream of p53 while p53 acts
as a bystander only responding to DNA damage. However, it
has been observed that p53 modulates cellular susceptibility to
ROS by dramatically influencing cellular ROS levels by en-
hancing pro-oxidant genes to promote apoptosis under
stressed conditions [265, 266]. For example, p53 utilizes
p66Shc to induce oxidative stress, cytochrome c oxidation,
and apoptosis [188] (Fig. 10). In addition, p53 can cause
uncoupling of ETC in mitochondria to generate ROS through
its targets BAX and PUMA [267]. This observation reflects
back to the conundrum where ROS, in normal and cancer
cells, can prove to be deleterious. It has been suggested that
the accumulation of ROS, while causing apoptosis and senes-
cence in non-transformed cells, can be equally lethal to the
cancer cells by causing senescence and apoptosis mediated by
tumor suppressor proteins [71].
The metabolic control by p53 can determine ROS levels as
p53 can increase ROS through OXPHOS and through sup-
pression of glycolysis. Two recently identified targets of p53
are utilized for this balance and include SCO2 [268] and
TIGAR [269]. p53 can increase ROS levels by targeting
cytochrome c oxidase through SCO2, or utilize TIGAR to
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suppress glycolysis. In cancers carrying mutated p53, SCO2
cannot be induced and hence cancer cells are protected against
ROS [270]. TIGAR activation has dual effects such that by
suppression of glycolysis, TIGAR prevents oncogenic trans-
formations, but by itself can suppress ROS and offer protec-
tion to a cancer cell. However, Madan et al. have shown that
TIGAR is induced by p53 under mild stress [271], thereby
choosing one of its antagonistic functions described above.
In addition to signaling pathways, p53 responds to oxygen
availability through redox modulations, conformational
changes and by inducing chaperones. Redox modulation of
p53 involves the thiol groups of cysteine present in two
regions of the p53 DNA-binding domain which help it to bind
to its consensus sequences [272]. Previously, p53 was de-
scribed as a metallo-protein that binds to zinc [272] and
mutations in the zinc-binding pocket of p53 compromise the
DNA-binding activity [29].
Reports also suggest that preservation of conformation of
p53 is essential in its functioning as p53 forms aggregates
during oxygen deprivations such as ischemia, and aggravates
diseases such as coronary heart disease [273]. In itself, p53
conformation is seen altered upon decreasing oxygen level as
assayed by an antibody raised against the mutant conforma-
tion of p53 (Mt-p53, the p53-240 conformation) which re-
covers upon normoxic conditions to wild-type conformation
(Wt-p53) as assayed by another antibody (p53-1620
conformation). In the study, p53 was assigned the role of a
molecular chaperone, such that its mutant conformation is
rescued by wild-type p53 protein [105] (Fig. 10). As a
follow-up of the study, it was observed that while hypoxia
leads to a mutant p53 conformation [105], treatment of tumors
in mice xenografts with oxygen in a cyclic manner caused
tumor regression in a p53-dependent manner [104], indicating
a new oxygen-dependent conformational regulation of p53.
Fig. 10 Oxygen controls p53 activity: a high oxygen levels increase
cellular ROS levels through mitochondria or Nox causing DNA damage,
thereby initially activating ATR-Chk1 mediated, and later ATM-Chk2-
mediated phosphorylations on p53, that in turn promote cell cycle arrest
or apoptosis. b (top) Under low oxygen, HIF1α increases p53 accumu-
lation by interacting with MDM2, while p53 negatively regulates HIF1α
resulting in a negative feedback loop. (bottom) p53 conformation is
controlled by oxygen. Low oxygen results in the mutant conformation
of p53 assayed by conformation specific antibody (p53-240 conforma-
tion) while high oxygen results in predominantly wild-type p53 confor-
mation assayed by conformation specific antibody (p53-1620 conforma-
tion). Normal oxygen levels have equal levels of normal and mutant p53
conformations
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Higher oxygen levels were able to bring about a specific set of
posttranslational modifications, significantly different from
those observed under hypoxia or normoxia [104].
Various posttranslational modifications of p53 have led to
the emergence of “smart-p53” versus “dumb-p53” model
[274]. In the former view, p53 undergoes these posttransla-
tional modifications to intelligently select its interaction with
promoters (to induce transcription) and other proteins to exert
tumor suppression [274] while in the latter view, the modifi-
cations of p53 by various proteins exclusively dictate its
function. It has been observed that stabilization, promoter
specificity, subcellular localization, transactivation functions,
etc. [275, 276] are mediated by the posttranslational modifi-
cations of p53.
Hypoxia is capable of regulating p53 ubiquitination
through regulation of HIF1a–MDM2 interaction [277] and
ubiquitination of p53 affects its localization (in addition to
controlling its levels) [278]. Mono-ubiquitinated p53 is
exported out of the nucleus [279] and localizes in the mito-
chondria [278]. Another oxygen-dependent posttranslational
modification of p53 occurs by the p300/CBP protein, which is
the common co-activator of p53 and HIF1α (Fig. 10). It has
been proposed that p300/CBP is under limited availability
during hypoxic stress [280], and HIF1α and p53 both compete
for p300 [281]. Another mechanism utilized by HIF1α is the
activation of cockayne syndrome B protein, which competes
for p53 binding with p300, making more p300 available for
HIF1α binding [281].
In addition to ubiquitination and acetylation, p53 activation
by phosphorylation is well known [282]. As described above,
p53 Ser15 is an important site for phosphorylation, and ATM/
ATR cooperate with Chk2-Chk1 for these phosphorylations.
Under hypoxia, DNA damage can lead to p53 phosphoryla-
tion. However, it is interesting to consider that protein phos-
phatase recruitment might also be affected by hypoxia, for
example by recruiting PNUTS (protein phosphatase-1 nuclear
targeting subunit) [277].
Recent reports show that sirtuins, a family of HDACs target
p53 [283] for deacetylation. The fact that sirtuin activity itself
depends on NAD+ (a redox cycler) causing deacetylation of
p53 itself links cellular redox status with posttranslational
modification of p53. It has been shown that SIRT inhibitors
that target SIRT1 and SIRT2 cause p53 acetylation, leading to
cell death [284]. Similarly, expression of SIRT1 under H2O2
or UV stress exerts cytoprotective effects by reversing stress-
induced p53 acetylation [285, 286]. Thus, changes in cellular
redox environment often found during altered metabolism in
cancer cell or aged cells can have implication in cell survival
[286] through sirtuins. This has been shown in aging Wistar
rats where an age-dependent decline in NAD+/NADH level
correlated with decreased SIRT1 activity and hence increased
p53 acetylation and cell death [286]. In addition to the previ-
ously mentioned posttranslational modifications in response
to oxygen, several other modifications of p53 are known. For
example, acetylation of p53 occurs by PCAF, hMOF, Tip60,
etc. in addition to SIRT1 and p300/CBP [287]. Similarly,
lysine residues of p53 undergo modifications such as methyl-
ation, sumoylation, and neddylation [278, 288]. As scientific
findings accumulate, the role of oxygen in these posttransla-
tional protein modifications will be better understood.
8.2 Summary
The importance of oxygen in regulation of cellular and mo-
lecular biology of life is a very complex research area. It
appears that altering oxygen levels cannot be considered as a
single parameter for analyzing its impact. The review suggests
that it is accompanied by other phenomena like redox-
homeostasis response, DNA damage, and ROS among others.
One thing is clear: oxygen impacts basic biological processes
and scientists have observed them at both the physiological
and molecular level. Yet somehow the role of oxygen as a
comprehensive research field is not in sights of the research
leaders. With this review, we wish to broaden the horizon and
spread awareness regarding the existence of an interesting and
untouched research area with immense opportunities of basic
science and therapeutic discoveries. We would like to coin the
terms like oxy-genomics, oxy-therapy, and oxy-biology for
the field leaders to notice and exhaust the great potential of
this field for achieving gain of knowledge and benefits to
patients.
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